Do molecular tests really differentiate malignant IPMNS from benign?

by Omer Basar, William R. Brugge
Published 2016-12-01

Screening for Pancreatic Adenocarcinoma in BRCA2 Mutation Carriers: Results of a Disease Simulation Model

by Pari V. Pandharipande, Alvin Jeon, Curtis R. Heberle, Emily C. Dowling, Chung Yin Kong, Daniel C. Chung, William R. Brugge, Chin Hur
Published 2015-12-01

The value of KRAS mutation testing with CEA for the diagnosis of pancreatic mucinous cysts

by Abdurrahman Kadayifci, Mohammad Al-Haddad, Mustafa Atar, John M. Dewitt, David G. Forcione, Stuart Sherman, Brenna W. Casey, Carlos Fernandez-del Castillo, C. Max Schmidt, Martha B. Pitman, William R. Brugge
Published 2016-03-01

Confocal endomicroscopy for evaluation of pancreatic cystic lesions: a systematic review and international Delphi consensus report

by Bertrand Napoleon, Somashekar G. Krishna, Bruno Marco, David Carr-Locke, Kenneth J. Chang, Àngels Ginès, Frank G. Gress, Alberto Larghi, Kofi W. Oppong, Laurent Palazzo, Pradermchai Kongkam, Carlos Robles-Medranda, Divyesh Sejpal, Damien Tan, William R. Brugge
Published 2020-10-01